Table 1 Characteristic of patients with alopecia areata and healthy controls.

From: Adiponectin as a novel biomarker of disease severity in alopecia areata

Parameter

Patients with AA (n = 65)

Healthy controls (n = 71)

Age, mean ± SD (years)

44 ± 17

46 ± 19

Sex (women/men)

49/16

53/18

BMI, mean ± SD (kg/m2)

24.78 ± 2.19

25.67 ± 3.21

Cholesterol, mean ± SD (mg/dl)

183.5 ± 20.5

179 ± 19

Low-density lipoprotein, mean ± SD (mg/dl)

109.5 ± 7.5

103 ± 6.5

High-density lipoprotein, mean ± SD (mg/dl)

65 ± 1

55 ± 1

Triglycerides, mean ± SD (mg/dl)

114.5 ± 21.5

123 ± 25.5

Fasting glucose, mean ± SD (mg/dl)

93 ± 17.5

96 ± 19.5

Duration of the episode of alopecia, mean ± SD (years)

3.55 ± 1.63

NA

SALT score, mean ± SD (%)

30 ± 37

NA

Severity of the disease (n)

 

NA

Patchy

51

 

Totalis

7

 

Universalis

719

 

Activity of the disease (n)

 

NA

Activea

21

 

Stableb

25

 

Remittingc

19

  1. BMI body mass index, SALT severity of alopecia tool, SD standard deviation, AA alopecia areata, NA not applicable.
  2. aActive alopecia areata—an increase in total hair loss of more than 5% during 1 month prior to laboratory tests.
  3. bStable alopecia areata—a change in total hair loss of less than 5% during 1 month prior to the laboratory tests.
  4. cRemitting alopecia areata—a decrease in total hair loss of more than 5% during 1 month prior to the laboratory tests.
Back to article page